
    
      Single-center, prospective, open-ended, interventional study with minimal risks and
      constraints. Patients will be divided into 3 groups: patients not infected with COVID-19,
      patients infected with COVID-19 not hospitalized, patients infected with COVID-19
      hospitalized.
    
  